Doxydox capsules has been found clinically effective in the treatment of a variety of infections caused by susceptible strains of Gram-positive and Gram-negative bacteria and certain other micro- organisms.

Respiratory tract infections:

Pneumonia and other lower respiratory tract infections. Mycoplasma pneumoniae pneumonia. Treatment of chronic bronchitis, sinusitis.

Urinary tract infections.

Sexually transmitted diseases:

Infections due to Chlamydia trachomatis including uncomplicated urethral, endocervical or rectal infections. 

Dermatological infections:

Acne vulgaris, when antibiotic therapy is considered necessary.

Ophthalmic infections:

Due to susceptible strains of gonococci, staphylococci and Haemophilus influenzae. Doxydox Capsules are indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence.

Rickettsial infections: Rocky Mountain spotted fever, typhus group, Q fever, Coxiella endocarditis and tick fevers.

Other infections: Psittacosis, cholera, meliodosis, leptospirosis, other infections due to susceptible strains of Yersinia species, Brucella species (in combination with Streptomycin), Clostridium species, Francisella tularensis and chloroquine-resistant falciparum malaria.